English | 繁體

Search in the results

UM

Browse/Search Results:  1-10 of 13 Help

Selected(0)Clear Items/Page:    Sort:
Fighting drug-resistant lung cancer by induction of NAD(P)H:quinone oxidoreductase 1 (NQO1)-mediated ferroptosis Journal article
Yu,Jie, Zhong,Bingling, Zhao,Lin, Hou,Ying, Ai,Nana, Lu,Jin Jian, Ge,Wei, Chen,Xiuping. Fighting drug-resistant lung cancer by induction of NAD(P)H:quinone oxidoreductase 1 (NQO1)-mediated ferroptosis[J]. Drug Resistance Updates, 2023, 70, 100977.
Authors:  Yu,Jie;  Zhong,Bingling;  Zhao,Lin;  Hou,Ying;  Ai,Nana; et al.
Favorite | TC[WOS]:27 TC[Scopus]:28  IF:15.8/18.1 | Submit date：2023/08/03
Drug-resistance  Ferroptosis  Lung Cancer  Mam  Nqo1  
Exogenous iron impairs the anti-cancer effect of ascorbic acid both in vitro and in vivo Journal article
Zhong, Bingling, Zhao, Lin, Yu, Jie, Hou, Ying, Ai, Nana, Lu, Jin Jian, Ge, Wei, Chen, Xiuping. Exogenous iron impairs the anti-cancer effect of ascorbic acid both in vitro and in vivo[J]. Journal of Advanced Research, 2023, 46, 149-158.
Authors:  Zhong, Bingling;  Zhao, Lin;  Yu, Jie;  Hou, Ying;  Ai, Nana; et al.
Favorite | TC[WOS]:10 TC[Scopus]:10  IF:11.4/11.0 | Submit date：2022/08/05
Ascorbic Acid  Ros  Ca2++  Iron  Necrosis  
Fighting cancer by triggering non-canonical mitochondrial permeability transition-driven necrosis through reactive oxygen species induction Journal article
Qingwen Xiao, Bingling Zhong, Ying Hou, Miaojuan Wang, Baojian Guo, Ligen Lin, Yinning Zhou, Xiuping Chen. Fighting cancer by triggering non-canonical mitochondrial permeability transition-driven necrosis through reactive oxygen species induction[J]. Free Radical Biology and Medicine, 2023, 202, 35-45.
Authors:  Qingwen Xiao;  Bingling Zhong;  Ying Hou;  Miaojuan Wang;  Baojian Guo; et al.
Favorite | TC[WOS]:10 TC[Scopus]:10  IF:7.1/7.9 | Submit date：2023/07/20
Isobavachalcone  Mitochondria  Mpt-driven Necrosis  Ros  
Nitrovin (difurazone), an antibacterial growth promoter, induces ROS-mediated paraptosis-like cell death by targeting thioredoxin reductase 1 (TrxR1) Journal article
Zhao, Lin, Zhong, Bingling, Zhu, Yanyan, Zheng, Haoyi, Wang, Xumei, Hou, Ying, Lu, Jin Jian, Ai, Nana, Guo, Xiuli, Ge, Wei, Ma, Yan Yan, Chen, Xiuping. Nitrovin (difurazone), an antibacterial growth promoter, induces ROS-mediated paraptosis-like cell death by targeting thioredoxin reductase 1 (TrxR1)[J]. Biochemical Pharmacology, 2023, 210, 115487.
Authors:  Zhao, Lin;  Zhong, Bingling;  Zhu, Yanyan;  Zheng, Haoyi;  Wang, Xumei; et al.
Favorite | TC[WOS]:10 TC[Scopus]:10  IF:5.3/5.2 | Submit date：2023/05/02
Nitrovin  Paraptosis  Trxr1  Ros  Glioblastoma  
Nannocystin ax, an eEF1A inhibitor, induces G1 cell cycle arrest and caspase-independent apoptosis through cyclin D1 downregulation in colon cancer in vivo Journal article
Hou, Ying, Liu, Rong, Xia, Mengwei, Sun, Chong, Zhong, Bingling, Yu, Jie, Ai, Nana, Lu, Jin Jian, Ge, Wei, Liu, Bo, Chen, Xiuping. Nannocystin ax, an eEF1A inhibitor, induces G1 cell cycle arrest and caspase-independent apoptosis through cyclin D1 downregulation in colon cancer in vivo[J]. Pharmacological Research, 2021, 173, 105870.
Authors:  Hou, Ying;  Liu, Rong;  Xia, Mengwei;  Sun, Chong;  Zhong, Bingling; et al.
Favorite | TC[WOS]:19 TC[Scopus]:18  IF:9.1/9.0 | Submit date：2021/12/08
Apoptosis  Cyclin D1  G1 Cell Cycle Arrest  Nannocystin Ax  
Therapeutic potential of isobavachalcone, a natural flavonoid, in murine experimental colitis by inhibiting NF-κB p65 Journal article
Zhou, Yishan, Zhong, Bingling, Min, Xiangjing, Hou, Ying, Lin, Ligen, Wu, Qin, Shi, Jingshan, Chen, Xiuping. Therapeutic potential of isobavachalcone, a natural flavonoid, in murine experimental colitis by inhibiting NF-κB p65[J]. Phytotherapy Research, 2021, 35(10), 5861-5870.
Authors:  Zhou, Yishan;  Zhong, Bingling;  Min, Xiangjing;  Hou, Ying;  Lin, Ligen; et al.
Favorite | TC[WOS]:20 TC[Scopus]:22  IF:6.1/7.0 | Submit date：2021/12/08
Inflammation  Isobavachalcone  Nf-κb P65  Ulcerative Colitis  
Receptor-interacting serine/threonine-protein kinase 1 (RIPK1) inhibitors Necrostatin-1 (Nec-1) and 7-Cl-O-Nec-1 (Nec-1s) are potent inhibitors of NAD(P)H: Quinone oxidoreductase 1 (NQO1) Journal article
Yu, Jie, Zhong, Bingling, Zhao, Lin, Hou, Ying, Wang, Xianzhe, Chen, Xiuping. Receptor-interacting serine/threonine-protein kinase 1 (RIPK1) inhibitors Necrostatin-1 (Nec-1) and 7-Cl-O-Nec-1 (Nec-1s) are potent inhibitors of NAD(P)H: Quinone oxidoreductase 1 (NQO1)[J]. FREE RADICAL BIOLOGY AND MEDICINE, 2021, 173, 64-69.
Authors:  Yu, Jie;  Zhong, Bingling;  Zhao, Lin;  Hou, Ying;  Wang, Xianzhe; et al.
Favorite | TC[WOS]:6 TC[Scopus]:7  IF:7.1/7.9 | Submit date：2021/12/08
Nec-1  Nec-1s  Nqo1  Ripk1  
A novel strategy for glioblastoma treatment by induction of noptosis, an NQO1-dependent necrosis Journal article
Zhong, Bingling, Yu, Jie, Hou, Ying, Ai, Nana, Ge, Wei, Lu, Jin Jian, Chen, Xiuping. A novel strategy for glioblastoma treatment by induction of noptosis, an NQO1-dependent necrosis[J]. Free Radical Biology and Medicine, 2021, 166, 104-115.
Authors:  Zhong, Bingling;  Yu, Jie;  Hou, Ying;  Ai, Nana;  Ge, Wei; et al.
Favorite | TC[WOS]:13 TC[Scopus]:12  IF:7.1/7.9 | Submit date：2021/09/17
Cell Death  Danshen  Noptosis  Nqo1  
Induction of programmed necrosis: A novel anti-cancer strategy for natural compounds Journal article
Jie Yu, Bingling Zhong, Qingwen Xiao, Lida Du, Ying Hou, Hong-Shuo Sun, Jin-Jian Lu, Xiuping Chen. Induction of programmed necrosis: A novel anti-cancer strategy for natural compounds[J]. HARMACOLOGY & THERAPEUTICS, 2020, 214, 107593.
Authors:  Jie Yu;  Bingling Zhong;  Qingwen Xiao;  Lida Du;  Ying Hou; et al.
Favorite | TC[WOS]:45 TC[Scopus]:49  IF:12.0/12.5 | Submit date：2021/03/01
Programmed Necrosis  Natural Compounds  Cancer  
2-Methoxy-6-acetyl-7-methyljuglone (MAM) induced programmed necrosis in glioblastoma by targeting NAD(P)H: Quinone oxidoreductase 1 (NQO1) Journal article
Yu, Jie, Zhong, Bingling, Jin, Long, Hou, Ying, Ai, Nana, Ge, Wei, Li, Luoxiang, Liu, Shuqin, Lu, Jin Jian, Chen, Xiuping. 2-Methoxy-6-acetyl-7-methyljuglone (MAM) induced programmed necrosis in glioblastoma by targeting NAD(P)H: Quinone oxidoreductase 1 (NQO1)[J]. Free Radical Biology and Medicine, 2020, 152, 336-347.
Authors:  Yu, Jie;  Zhong, Bingling;  Jin, Long;  Hou, Ying;  Ai, Nana; et al.
Favorite | TC[WOS]:25 TC[Scopus]:27  IF:7.1/7.9 | Submit date：2021/09/17
Mam  Glioblastoma  Programmed Necrosis  Nqo1